Machine perfusion improves solid organ preservation for transplantation. We have demonstrated that antegrade perfusion preservation of hearts is superior to cold storage but may be limited by aortic valve incompetence. We hypothesized that retrograde perfusion (RP) through the coronary sinus may provide more reliable perfusate delivery to the heart. This study was designed to determine the optimal perfusion parameters and evaluate regional flow after RP of canine hearts. After donor cardiectomy, canine hearts (n ‫؍‬ 6) were established in a perfusion device (LifeCradle, Organ Transport Systems, Inc., Frisco, TX) through a coronary sinus catheter. Hearts were perfused at 5°C over flow rates from 10 to 35 ml/100 g myocardium/min for 20 minutes at each flow rate. Colored microspheres were used to quantify tissue perfusion. Oxygen consumption (MVO 2 ) and perfusion parameters were measured. At end-perfusion, tissue was collected for proton magnetic resonance spectroscopy ( Machine perfusion for preservation of donor hearts has been investigated for nearly 50 years. 1 This strategy offers a number of potential benefits for improving preservation of donor hearts and extending the donor pool including: 1) tolerance of prolonged donor ischemic intervals and long-distance procurements; 2) utilization of extended donors; 3) resuscitation of injured hearts; 4) better donor-recipient matching (such as by human leukocyte antigens). 1,2 It is therefore surprising that this technique has not gained greater enthusiasm despite improved clinical results after kidney transplantation and improved myocardial preservation in animal models of short-and long-term heart preservation. 4 -7 Virtually, all previous studies of machine perfusion preservation of hearts involve antegrade coronary artery perfusate delivery through the aortic root. Our laboratory has previously demonstrated that although antegrade perfusion preservation of hearts is superior to standard hypothermic cold storage, this technique may be limited by aortic valve incompetence, a factor which may in part explain the reluctance to develop this technology for cardiac transplantation. We demonstrated that this limitation can potentially be avoided with an initial high flow of perfusion solution to allow for aortic valve leaflet closure before initiation of standard cold perfusion flow rates. 8 However, adequate aortic valve closure is difficult to verify in the explanted, perfused heart. Also, these experiments were performed in a laboratory setting with a stable perfusate delivery platform. One would anticipate that transport of donor hearts either by air or ground could risk further distraction of aortic valve leaflets and worsen aortic insufficiency, thereby decreasing myocardial perfusion and nutrient flow when applying an antegrade perfusion technique. For standard ischemic intervals, this would be of minor consequence as hearts would essentially be undergoing static storage. For extended, long-term storage or when resuscitating injured donor organs, inadequate myocardial perfusion could have catastrophic sequelae.
Machine perfusion for preservation of donor hearts has been investigated for nearly 50 years. 1 This strategy offers a number of potential benefits for improving preservation of donor hearts and extending the donor pool including: 1) tolerance of prolonged donor ischemic intervals and long-distance procurements; 2) utilization of extended donors; 3) resuscitation of injured hearts; 4) better donor-recipient matching (such as by human leukocyte antigens). 1, 2 It is therefore surprising that this technique has not gained greater enthusiasm despite improved clinical results after kidney transplantation and improved myocardial preservation in animal models of short-and long-term heart preservation. 4 -7 Virtually, all previous studies of machine perfusion preservation of hearts involve antegrade coronary artery perfusate delivery through the aortic root. Our laboratory has previously demonstrated that although antegrade perfusion preservation of hearts is superior to standard hypothermic cold storage, this technique may be limited by aortic valve incompetence, a factor which may in part explain the reluctance to develop this technology for cardiac transplantation. We demonstrated that this limitation can potentially be avoided with an initial high flow of perfusion solution to allow for aortic valve leaflet closure before initiation of standard cold perfusion flow rates. 8 However, adequate aortic valve closure is difficult to verify in the explanted, perfused heart. Also, these experiments were performed in a laboratory setting with a stable perfusate delivery platform. One would anticipate that transport of donor hearts either by air or ground could risk further distraction of aortic valve leaflets and worsen aortic insufficiency, thereby decreasing myocardial perfusion and nutrient flow when applying an antegrade perfusion technique. For standard ischemic intervals, this would be of minor consequence as hearts would essentially be undergoing static storage. For extended, long-term storage or when resuscitating injured donor organs, inadequate myocardial perfusion could have catastrophic sequelae.
An alternate strategy for machine perfusion of hearts involves RP through the coronary sinus. Using a standard retrograde cardioplegia catheter, preservation solution can be delivered directly into the coronary venous system. 9 This technique avoids the issue of aortic valve incompetence. In addition, perfusion with oxygenated blood cardioplegia can be continued during the implantation period, virtually eliminating the detrimental effects of the warm ischemic interval. 10 Retrograde cardioplegia by perfusion through the coronary sinus is used routinely for myocardial protection during cardiac surgery. [11] [12] [13] Although RP is a reliable method of delivering cardioplegia for cardiac surgery, its efficacy for preservation of myocardium under deep hypothermia and ex vivo perfusion of hearts is not known. RP has rarely been used for preserving donor hearts, and optimal perfusion parameters for this application will need to be defined. 14 In addition, differences in regional myocardial perfusion, particularly of the right ventricle, may be a limitation with retrograde perfusate delivery. [15] [16] [17] Because of these concerns, we decided to investigate retrograde coronary sinus perfusion for preservation of hearts for transplantation. This study was designed to determine the optimal perfusion parameters and evaluate regional myocardial flow during RP of canine hearts.
Methods
The protocol for this study was approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center. All animals were treated within guidelines set forth in the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 86-23, revised 1996). Adult mongrel dogs (n ϭ 6, average weight 28.6 Ϯ 3.6 kg, range 24.1-34.0 kg) were used in this experiment. In each experiment, hearts were removed from anesthetized dogs and established in a study perfusion device that provided continuous perfusion of oxygenated fluid through a calibrated pump system that enabled precise control of flow rate, oxygenation, and fluid temperature (LifeCradle, Organ Transport Systems, Inc., Frisco, TX). The hearts were flushed antegrade with University of Wisconsin Machine Perfusion Solution (UW-MPS) to achieve a diastolic arrest, connected to the perfusion device with a coronary sinus catheter (Medtronic Inc., Minneapolis, MN), and perfused with varying flow rates from 10 ml/100 g/min to 35 ml/100 g heart weight/min at 5°C Ϯ 2°C for 20-minute intervals with UW-MPS. The catheter was secured to the coronary sinus ostium with a 4-0 prolene suture. Also, the balloon was not inflated to avoid malperfusion of the posterior descending and right ventricular venous system. The device inflow line pressure was measured with a fluid-filled high pressure line. The actual direct coronary sinus pressure was measured with a Traceable manometer (Fisher Scientific, Inc., Waltham, MA). A schematic of the device, images of the disposable unit, and loaded prototype version of the device are shown in Figure 1A -C.
Colored microspheres [colors-pink high (9,119 Ϯ 666 beads/ml), yellow high (10,104 Ϯ 930 beads/ml), purple high (11,994 Ϯ 2,114 beads/ml), purple medium (9,522 Ϯ 691 beads/ml), coral high (9,548 Ϯ 570 beads/ml), coral medium (12,541 Ϯ 1,148 beads/ml)] were used to quantify nutrient flow to the tissues (IMT Laboratories, Irvine, CA) as previously described. 8 To perform this analysis, the heart was gently repositioned from the perfusion chamber to the sampling container, the side branch of the perfusate delivery line was opened, and the recirulating line was clamped to allow delivery of the bead-containing solution into the device through the inflow cannula for 2 minutes at the same flow rate without recirculation. A sample of the bead solution was collected for bead quantification. After 2 minutes, the inflow was switched to the alternative (washout) solution to clear any beads from the tubing by flowing at the same rate for a time calculated to deliver 120 ml of solution from the chamber. At this point, the heart was returned to the initial perfusion chamber and the second randomly selected flow rate was dialed in. The bead solution was changed to one with a different color of beads. After 20 minutes, the sequence was repeated. This process continued until all six flow rates were completed. After the final washout, the heart was removed from the sampling chamber. The heart was dissected, and a 1-cm slice at the midventricular level was obtained to quantify segmental perfusion. Tissue samples (2-3 g) of endocardial and epicardial tissue from the anterior, lateral, and inferior left ventricle, the LV and RV septum, the RV free wall, and the left atrial appendage were harvested and stored. In addition, fluid samples from the overflow and perfusion device chambers were collected, and the final volume of both chambers was measured. Bead counts of fluid samples and digested tissue were quantified with a NuFlow cytometer (IMT Laboratories, Irvine, CA).
Myocardial tissue perfusion rates and the fraction of nonnutrient flow were calculated by measuring the number of beads collected in the sampling container for each flow rate and dividing this by the total number of delivered beads. The nutrient flow fraction was then calculated as 1 Ϫ the fraction of beads collected in the sampling container (i.e., the non-nutrient flow fraction) for each flow rate. Nutrient flow was then determined by multiplying the nutrient flow fraction by the delivered volume per 100 g cardiac tissue per minute for each flow rate. Nutrient flow calculations were based on the bead data from the sampling container only. Subsequent bead loss into the perfusion chamber was measured but assumed to represent nutrient flow as it occurred after the washout period. Regional myocardial perfusion, expressed as the fraction predicted from the nutrient flow calculation, was determined in tissue by digesting the tissue, recovering entrapped beads, and by dividing the entrapped microsphere count per gram myocardial tissue by the expected bead count per gram from the nutrient flow calculation.
Temperature and pressure were measured continuously in perfused hearts. Oxygen consumption (MVO 2 ) was calculated from inflow pO 2 , outflow pO 2 (drawn from the left and right coronary arteries), and the actual delivered flow rate. At endperfusion, tissue samples of left and right ventricle were collected for proton magnetic resonance spectroscopy ( 1 H MRS). The tissue samples were harvested, immediately freezeclamped, and cooled in liquid nitrogen. The tissue was stored in a Ϫ80°C freezer and extracted subsequently with perchloric acid. Purified extracts were reconstituted in D 2 O, and pH was adjusted to 7.0 -7.4 for magnetic resonance spectroscopy (MRS). Proton ( 1 H) magnetic resonance spectra were then acquired with a 14.1 Tesla Varian spectrometer operating at 600 MHz over a spectral width of 8,000 Hz. Lactate/alanine ratios were compared from 1 H spectra as measures of cellular aerobic and anaerobic metabolism during storage. Wet/dry ratios and myocardial water content were determined from separate duplicate RV and LV samples.
Data were analyzed with SigmaPlot statistical software (SyStat Software, Inc., San Jose, CA) using a two-sided t test or analysis of variance (ANOVA), as appropriate. When data were collected over multiple time points, a repeated-measures ANOVA was applied. A p value Ͻ0.05 was considered significant.
Results
Hypothermia was maintained at all flow rates. The average total perfusion preservation period (donor ischemic time) was 204 Ϯ 14 minutes. Heart weight increased significantly over the perfusion interval from 211 Ϯ 30 to 267 Ϯ 43 g (⌬ 27%, p ϭ 0.03). Coronary sinus pressures increased with increasing flow rates, but this difference did not reach statistical significance (p ϭ 0.13). Calculated nutrient flow increased over the range of delivered device flow rates. This difference was significant for each 10 ml/100 g/min flow increment (p Ͻ 0.05). MVO 2 was calculated using the left coronary artery outflow sample only. Flow in the right coronary artery was low and did not yield meaningful data. Small increases in MVO 2 were noted up to 20 ml/100 g/min, but this difference was not statistically significant compared with the lower two flow rates (10 and 15 ml/100 g/min) ( Table 1) .
Total RV and left atrial nutrient flows were significantly reduced at all flow rates except 10 ml/100 g/min compared with LV nutrient flow (p Ͻ 0.05) (Figure 2 ). There were no Data are given as mean Ϯ 1 SD. * p Ͻ 0.05 vs. all flow rates 10 ml/100 g/min less than index flow rate. † Data are derived from actual delivered flows from microsphere studies.
differences in epicardial and endocardial perfusate delivery within all myocardial segments (data not shown). Nutrient flow among all RV segments (RV free wall, RV septum) and LV segments (anterior, lateral, inferior, septal) was similar (data not shown). Myocardial water content and wet/dry ratios at the end of each experiment were lower in right ventricular samples ( Table 2) . Lactate/alanine ratios were low in all LV samples, consistent with ongoing oxidative metabolism. However, lactate/alanine ratios were increased in RV tissue, again suggesting reduced RV perfusion although this difference did not quite reach statistical significance (p ϭ 0.09). The highest lactate/alanine ratios were noted in left atrial samples consistent with reduced oxygen delivery and potentially anaerobic metabolism. This increase was significant compared with LV (p Ͻ 0.01) but not RV tissue (p ϭ 0.14) (Figure 3) . Representative 1 H magnetic resonance regional spectra from each region of myocardium are shown in Figure 4 . Discussion Pratt 18 first described that RP through the coronary venous system could be used to support the heart of a cat. Subsequently, Lillehei et al. 19 reported the first clinical application of this technique in a patient with aortic stenosis. Since then, retrograde cardioplegia has evolved as an effective technique for myocardial protection during cardiac surgery. A number of clinical and experimental studies support the use of RP for maintaining the myocardium during both depolarized cardioplegic arrest and normokalemic perfusion. 13,20 -23 The enthusiasm for RP is not uniform. Although retrograde cardioplegia is an established technique for myocardial protection during cardiac surgery, concerns regarding the distribution of RP have been raised. Tian et al. 17, 24 reported that global nutrient delivery and myocardial energetics are less well supported by RP compared with antegrade perfusion at the same flow rates and proposed higher RP pressures and flow rates to overcome this limitation. Other authors suggest that RV protection, in particular, might be compromised because some portion of the blood supplying the right ventricle drains directly into the right atrium and ventricle, bypassing the coronary sinus. 9 Smith et al. 15 and Partington et al. 25 reported reduced RV perfusion using retrograde microsphere perfusion of canine hearts, particularly in the presence of patent coronary arteries as would be expected in organs procured for transplantation. Concerns regarding RV perfusion by coronary sinus perfusion have not been borne out in most human studies and may be due to differences between canine and human cardiac venous anatomy. 9 In this study, RP preservation resulted in excellent LV protection with similar MVO 2 and indices of metabolism compared with our previous antegrade machine perfusion studies except at the lowest evaluated flow rate. 6, 8, 26 RV MVO 2 could not be assessed due to inadequate right coronary artery effluent. Perfusion and metabolic parameters as measured by the lactate/alanine ratio and microsphere data also suggest that RV perfusion is impaired to some extent, a phenomenon that appeared to be independent of the flow rate. Left atrial flow also was reduced as assessed by nutrient flow and metabolic data. This reduction in left atrial flow would not seem surprising as the left atrium is transected during procurement and the lowest resistance drainage from the left atrial venous system would be directly into the perfusate, bypassing capillary beds.
Increased myocardial water content and edema are potential concerns when using machine perfusion for preservation of donor hearts. LV myocardial water content was higher in this study compared with values previously reported with antegrade perfusion using the same preservation solution. This might be due in part to the effect of the higher flow rates used during this study compared with antegrade perfusion experiments. RV myocardial water content was lower which may reflect reduced perfusion of RV capillary beds as documented by the microsphere data. Interestingly, similar increases in myocardial water content in an antegrade machine perfusion model from our laboratory did not impact reperfusion heart function and myocardial water content after transplantation was not different compared with static controls, suggesting that the impact of heart weight gain during storage is uncertain. 27 One of the reported benefits of machine perfusion preservation is the ability to support the metabolic demands of the stored organs during the preservation interval. We have previously reported the use of lactate/alanine ratio by 1 H MRS as a simple measure to differentiate aerobic metabolism and anaerobic metabolism. 6, 7, 26, 27 This ratio takes advantage of the compartmentalization of anaerobic glycolysis and oxidative glucose metabolism. 28, 29 Although alanine does not directly participate in oxidative energy generating pathways (citric acid cycle), observed increases in intracellular alanine compared with lactate seem to be an indicator of increased oxidative metabolism as well, when assessed directly with labeled substrates. 27 In this study, LV oxidative metabolism appears preserved and the low lactate/alanine ratios are quite similar to previously reported data for antegrade perfused hearts. 26 Left atrial spectra demonstrated significantly increased lactate/ alanine ratios similar to spectra from static storage hearts and are more consistent with anaerobic metabolism and reduced nutrient flow. Lactate/alanine ratios were intermediate for RV tissue, suggesting at least reduced perfusion of the right ventricle and RV septum. These data are consistent with findings from the microsphere experiments and indicate that oxygenated perfusate delivery to the right ventricle may be insufficient to support oxidative metabolism with this technique. The impact of reduced nutrient delivery during storage on reperfusion RV function is uncertain. RV dysfunction after transplantation is multifactorial. It includes donor factors (RV dysfunction after brain death, donor management strategies), recipient factors (RV strain from increased pulmonary vascular resistance), and technical aspects during reimplantation (warm ischemic time) which may be as important as the metabolic state of the right ventricle during perfusion preservation. 30, 31 This study has several limitations. First, important differences in coronary venous anatomy especially affecting RV drainage have been reported between canine and human hearts. 9,21 MVO 2 calculations represent estimates only of cardiac oxygen consumption as the vast majority of the perfusate appears to have drained through the venous system. Flow rates in this study were assigned in random order and therefore might have affected metabolic data in samples taken from hearts that finished with high versus low flow rates. However, lactate/alanine ratios and MVO 2 data were similar independent of the final experimental flow rate. Only the reduced LV perfusion at 10 ml/100 g/min by microsphere analysis suggests that perfusion at the lowest examined flow rate may be inadequate to support the metabolic demands of the LV. RV perfusion was reduced independent of the delivered flow rate and perfusion pressure. In summary, retrograde machine perfusion of canine hearts provides effective LV perfusion, maintains myocardial oxygen delivery, and supports myocardial oxidative metabolism at flow rates of 15 ml/100 g/min or higher. RV perfusion is reduced at all evaluated flow rates and may not be sufficient to support oxidative metabolism of the right ventricle. These data may have important implications for application of machine perfusion to preservation of human hearts for transplantation. 
